Literature DB >> 26028662

Coronary flow velocity reserve in donor artery and myocardial performance index after successful recanalization of chronic total coronary occlusions.

Ahmet Oytun Baykan1, Gülhan Yüksel Kalkan, Durmus Yıldıray Sahin, Zafer Elbasan, Mustafa Gur, Taner Seker, Caner Turkoglu, Murat Caylı.   

Abstract

BACKGROUND: Percutaneous recanalization of chronic total coronary occlusion (CTO) tends to show a positive effect on left ventricular remodeling and ejection fraction (LVEF). Coronary flow velocity reserve (CFVR) is an important diagnostic index of the functional capacity of coronary arteries. The aim of this study was to evaluate, by non-invasive CFVR, whether the blood flow of donor artery reverts to normal after CTO percutaneous coronary intervention (PCI). Also, we assessed the effects of CTO recanalization on global cardiac functions by using myocardial performance index (MPI).
METHODS: We evaluated 25 patients (mean age, 57.5 ± 14.1 years) who underwent CTO-PCI of the right coronary artery, whose collaterals were provided by the left anterior descending (LAD) artery. The coronary flow velocities in the distal LAD were measured using transthoracic echocardiography (TTE) before, 24 hours after, and within 3 months of PCI. Both two-dimensional and tissue Doppler (tD) echocardiography were used to calculate MPI.
RESULTS: CFVR at month 3 was significantly increased compared to the basal and early CFVR (1.8 ± 0.3 vs. 2.3 ± 0.3 [P<.001] and 1.8 ± 0.2 vs. 2.3 ± 0.3 [P<.001], respectively). MPI at month 3 was significantly decreased compared to the basal and early MPI (0.61 ± 0.09 vs. 0.53 ± 0.07 [P<.001] and 0.60 ± 0.08 vs. 0.53 ± 0.07 [P<.001], respectively). Also, tD-MPI within 3 months was significantly decreased (0.58 ± 0.9 vs. 0.53 ± 0.8 [P=.01] and 0.57 ± 0.07 vs. 0.53 ± 0.8 [P<.001], respectively, for tD-MPI septal and 0.59 ± 0.08 vs. 0.51 ± 0.07 [P<.001] and 0.58 ± 0.08 vs. 0.51 ± 0.07 [P<.001], respectively, for tD-MPI lateral).
CONCLUSION: Successful recanalization of CTO results in increased CFVR-indicated blood flow in the donor artery and MPI-indicated global cardiac functions.

Entities:  

Mesh:

Year:  2015        PMID: 26028662

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow.

Authors:  Hongmei Niu; Zhenzhen Wei; Yanling Zhang; Jian He; Danyan Jia
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

2.  Prompt and consistent improvement of coronary flow velocity reserve following successful recanalization of the coronary chronic total occlusion in patients with viable myocardium.

Authors:  Milan Dobric; Branko Beleslin; Milorad Tesic; Ana Djordjevic Dikic; Sinisa Stojkovic; Vojislav Giga; Miloje Tomasevic; Ivana Jovanovic; Olga Petrovic; Jelena Rakocevic; Nikola Boskovic; Dragana Sobic Saranovic; Goran Stankovic; Vladan Vukcevic; Dejan Orlic; Dragan Simic; Milan A Nedeljkovic; Srdjan Aleksandric; Stefan Juricic; Miodrag Ostojic
Journal:  Cardiovasc Ultrasound       Date:  2020-07-21       Impact factor: 2.062

3.  Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221/VEGFA axis.

Authors:  Lihua Sun; Ying Zhang; Junshi Zhang; Juan Wang; Shifeng Xing
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.